Should You Take Hormone Replacement Therapy (HRT)?
We created a tool to help you sift through the noise.
Spend five minutes in any menopause group online and you'll see the same scene: a woman with confusing symptoms, a chorus telling her to "just get on hormones," and a lot of confident claims that hormone therapy is perfectly safe and doesn't increase cancer risk. I see it differently. As clinicians specializing in perimenopause/menopause, we have watched HRT (preferably called Menopausal Hormone Therapy (MHT) by The Menopause Society) help the right woman and harm the wrong one — and the difference usually comes down to something the popular advice skips entirely: your lifetime estrogen exposure, your personal and family history and risk profile, and how your own genetics move estrogen down the protective road versus the riskier one. Hormones are a tool, not a cure-all, and they're only one of many ways through this transition. This tool won't hand you a prescription or a verdict. It will help you weigh the real risks and benefits — honestly — so you can make an educated decision with a clinician who treats you as an individual, not a population average.
Menopause is normal — and MHT (HRT) isn't the only road through it
The menopausal transition is a normal part of life, and not every woman needs hormones to feel well. For moderate-to-severe hot flashes, vaginal changes, and bone protection, hormone therapy is genuinely effective, and for many women who begin under 60 or within about ten years of menopause it's reasonable to consider. But somewhere along the way, "a helpful tool for some women" turned into "everyone should be on hormones" — and that's where I part ways with the loudest voices online. Whether Menopausal Hormone Therapy (also known as Hormone Replacement Therapy) is right for you depends on your whole picture, and there are effective, evidence-based alternatives for nearly every symptom.
The part the headlines skip: your lifetime estrogen exposure
Estrogen is a wonderful thing — it protects your heart and bones and supports your brain, mood, sleep, skin, and joints. But like any good thing, it has a downside, and the concern is exposure over a lifetime. Picture your estrogen exposure as the area under a curve that spikes in puberty, cycles through your reproductive years, and drops in menopause. The larger that area, the higher the risk for estrogen-related conditions like breast cancer (particularly in women who don't metabolize and clear their estrogens well). Menopausal hormone therapy can extend that exposure past menopause — which is exactly why it deserves a real conversation about your individual risk before you start, not a rubber stamp.
The different roads of estrogen — and why your genetics matter
Your body doesn't just make estrogen; it has to clear it. And it can send estrogen down more than one road. The 2-OH pathway is the gentler, protective route that clears easily. The 4-OH pathway is the riskier one — it can form reactive compounds that damage DNA and are linked to breast and uterine cancer. Which road your body favors is partly genetic: enzymes like CYP1A1 push estrogen toward the protective form and CYP1B1 toward the riskier one, while your "cleanup crew" — CYP3A4 and COMT — determines how quickly you clear it all. Wouldn't you want to know whether your body tends to send estrogen down the protective road or the proliferative one before you decide to add more of it? We ensure you have this information before making a decision about MHT.
What this tool weighs
This tool walks through the factors that actually belong in the decision: your age and where you are in the transition; which symptoms are bothering you, and how well MHT truly helps each one (some far more than others); your personal and family history; and a plain-language primer on the estrogen-metabolism genes above. It also surfaces evidence-based, non-hormonal options for every symptom, because for many women those are a legitimate first step. It won't score you or hand you a verdict — it gives you a balanced, personalized summary to talk through with a clinician.
The honest points most quizzes skip
A few things this tool won't gloss over. Hormone therapy protects bone only while you take it — stop, and within a few years your fracture risk drifts back toward baseline, so it isn't a stand-alone long-term plan (though treating active bone loss now can be appropriate). MHT is not a weight-loss treatment; menopausal weight gain has far more to do with cortisol, blood sugar, inflammation, and sleep than with estrogen. And for many symptoms blamed on hormones — brain fog, joint pain, low libido — the real driver is often inflammation, elevated cortisol, or poor sleep. Route matters, too: for women with certain clotting risks (that many doctors don't test for), MHT may not be appropriate.
There are real alternatives
If you'd rather not start hormones — or you're not a good candidate — you have options, and good ones. Non-hormonal medications (including the newer NKB-blockers for hot flashes), well-studied herbs and nutraceuticals, and targeted lifestyle work aimed at the root cause — cortisol, blood sugar, inflammation, thyroid, sleep — carry many women comfortably through this transition. The right plan depends on you, which is where a genetics-informed, naturopathic approach earns its keep.
Talk it through — the Avra Health way
This guide is a starting point, not a decision. In my practice, I evaluate genetics on every patient before building a hormone plan — because "first, do no harm" means understanding your individual risk before adding estrogen, not after. If you'd like a clinician to weigh your history, your risks, and your genetics together — and map out the right approach for you, hormonal or not — you can book a consultation below.
About the Author
Avra Health was founded by Dr. April Graham, ND, a naturopathic doctor focused on integrative, genetics-informed perimenopause and menopause care. Taking a calm, collaborative approach, I guide you to understand your genetic insights and develop practical strategies for your well-being. Together, we'll create a tailored path to health that empowers you to make informed choices.
This is for education and information only — it isn't medical advice, and it doesn't create a doctor–patient relationship. Please talk with your healthcare provider before making any changes to your health plan.
FAQ's
It's not that simple — and "MHT is perfectly safe" is an overstatement. The strongest reassurance comes from studies that used older formulations and, importantly, didn't account for individual genetics. Most breast cancers are estrogen-driven, and some women genetically metabolize estrogen into a more potent, DNA-damaging form. Hormone therapy extends your estrogen exposure past menopause, so whether it raises your risk depends a great deal on your own biology. It can be reasonable for some women and the wrong choice for others — which is exactly why individual risk, history, and genetics belong in the conversation.
For some women, yes; for others, no. If you're under 60 or within about ten years of menopause with bothersome hot flashes or vaginal symptoms, MHT can be a reasonable option. But it's an individualized decision — your symptoms, personal and family history, lifetime estrogen exposure, and genetics all shift the balance, and there are effective alternatives for most symptoms. This tool helps you weigh your own picture.
Not at all. Menopause is a normal transition, and many women do beautifully without hormones. There are effective, evidence-based alternatives for the main symptoms — non-hormonal medications, well-studied herbs and nutraceuticals, and root-cause lifestyle work on sleep, stress and cortisol, blood sugar, and inflammation. For many women, those aren't a fallback — they're the better path.
For clot and stroke risk, transdermal estrogen (a patch or gel) is believed to be generally safer than pills, because it largely avoids the clot-promoting effect that oral estrogen has - however, the evidence is limited. Which is right for you depends on your risk factors — a conversation to have with your clinician.
Your genetics can't give a yes-or-no, but they fill in a big gap in your risk profile. Enzymes like CYP1A1, CYP1B1, CYP3A4, and COMT influence whether your body sends estrogen down the protective 2-OH road or the riskier 4-OH road, and how quickly you clear it. That's genuinely useful context — but it's exploratory, and it belongs with a clinician who can interpret it alongside your history, not an automated at-home readout.
MHT is not a weight-loss treatment. The best study showed only a very modest effect — around 1.4 pounds over five years. Menopausal weight gain has far more to do with cortisol, blood sugar, inflammation, and sleep, which is where the real solutions are — and where understanding your genetics helps you focus your energy.
No — and this is a common misunderstanding. About 85% of breast cancers occur in women with no family history, largely from genetic changes that accumulate with age and environmental exposures. A clean family tree isn't full reassurance, and a family history doesn't automatically rule MHT out. It's one piece of a larger, individual picture.